Medtech companies directory 2026
Medical Device Companies in South Korea
Samsung Medison, Alpinion, Osstem, Vatech, Lunit and Seegene are the Korean houses a biomedical engineer and a laboratory director already know — ultrasound, implants, dental imaging, AI readout, molecular IVD. Siemens Healthineers Korea holds a large imaging and lab installed base beside GE and Philips seats. The Ministry of Food and Drug Safety is the device gate; the National Health Insurance Service and HIRA write the codes that make a premium implant or an AI readout economically usable. Hospital procurement at the five majors is committee-led and brand-sticky. BioNixus interviews those named committees, not a generic “Korea hospital” cell.
Updated September 2026 · MFDS — Ministry of Food and Drug Safety, medical device approval and surveillance as of September 2026 · 16 named accounts
MFDS
Ministry of Food and Drug Safety — Korean device approval and post-market owner
NHIS / HIRA
Insurer and review agency whose codes decide whether a premium SKU is claimable
Big 5
Asan, SMC, Severance, SNUH and St. Mary’s — tertiary committees that set the tray
Export
Korean ultrasound, dental and IVD houses that sell abroad from the same factories
Named accounts
Top medical device companies in South Korea
| # | Company | HQ | Type | Device categories | Notes |
|---|---|---|---|---|---|
| 01 | MFDS (Ministry of Food and Drug Safety) | Osong | Government | ||
| 02 | NHIS / HIRA hospital reimbursement and procurement overlay | Wonju / Seoul | Government | ||
| 03 | Samsung Medison | Seoul | Local | ||
| 04 | Alpinion Medical Systems | Seoul | Local | ||
| 05 | Osstem Implant | Seoul | Local | ||
| 06 | Vatech | Hwaseong | Local | ||
| 07 | Lunit | Seoul | Local | ||
| 08 | Seegene | Seoul | Local | ||
| 09 | Siemens Healthineers Korea | Seoul | MNC | ||
| 10 | GE HealthCare Korea | Seoul | MNC | ||
| 11 | Medtronic Korea | Seoul | MNC | ||
| 12 | Asan / SMC / Severance / SNUH / St. Mary’s procurement | Seoul | Operator | ||
| 13 | Korean device importers (수입업체) | Seoul / Gyeonggi | Distributor | ||
| 14 | Philips Korea (Health Systems) | Seoul | MNC | ||
| 15 | Secondary hospital and clinic-chain buying groups | Nationwide | Operator | ||
| 16 | Sewoon Medical / domestic consumable makers | Multiple | Local |
Primary research
These are the medical device companies accounts we study in South Korea
Need account-level or SKU-level data for a brand in South Korea? BioNixus runs primary fieldwork — brand vs competitors, including the channels a dashboard averages away. Proposal ready within 48 hours of a brief.
Planning research in South Korea?
Primary research, market access & HEOR. Proposals within 48 hours.
How the market is structured
MFDS file, HIRA code, tertiary committee
Local
Korean ultrasound, dental, AI and IVD houses whose factories already feed tertiary rooms, clinic chains and export containers.
- Samsung Medison
- Alpinion Medical Systems
- Osstem Implant
- Vatech
- Lunit
- Seegene
- Sewoon Medical / domestic consumable makers
Multinational
Seoul multinational seats that hold Big Five imaging and implant share and still share secondary-hospital invoices with 수입업체.
- Siemens Healthineers Korea
- GE HealthCare Korea
- Medtronic Korea
- Philips Korea (Health Systems)
Regional
Importers and secondary-hospital dealers who hold the MFDS file and the vendor code outside the five Seoul majors.
Distributors & service partners
MFDS as the Osong gate, NHIS and HIRA as the claim code, Big Five committees as the tertiary tray.
- MFDS (Ministry of Food and Drug Safety)
- NHIS / HIRA hospital reimbursement and procurement overlay
- Asan / SMC / Severance / SNUH / St. Mary’s procurement
- Korean device importers (수입업체)
- Secondary hospital and clinic-chain buying groups
What is moving
What is moving the medical device market in South Korea
HIRA code timing versus MFDS clearance
A cleared AI or implant SKU that lacks a claim path dies in the budget meeting; BioNixus dates the code, not only the licence.
Big Five capital-committee cycles
Asan, SMC, Severance, SNUH and St. Mary’s refresh ultrasound, CT and lab automation on separate calendars that a single Seoul dinner will not unlock.
Dental and clinic-chain volume
Osstem and Vatech make their Korean numbers in clinics, not in Asan radiology; a tertiary-only brief under-counts the domestic champions.
Export factories versus domestic adoption
Wonju and Songdo export success does not mean the same SKU is on a Korean tertiary tray; BioNixus splits those two facts.
BioNixus fieldwork
How BioNixus studies medical device companies in South Korea
- Big Five equipment-committee interviews treated as five buyers, never as one Seoul average.
- HIRA-code versus MFDS-licence date checks on AI and implant SKUs that cleared but never claimed.
- Clinic-chain CBCT and implant installed-base counts for Vatech and Osstem outside tertiary radiology.
- 수입업체 coverage scores so a Seoul multinational seat is not counted as secondary-hospital last-mile.
Questions
Frequently Asked Questions
How are medical devices approved in South Korea?
MFDS in Osong licences the manufacturer or importer. Classification drives the file. A hospital committee will ask for that licence number before it opens an evaluation.
How does NHIS reimbursement affect device use?
HIRA codes decide whether the hospital can claim the SKU. Non-covered devices need a hospital-budget story. Many AI and premium implant launches stall on this gate, not on MFDS.
Who are the Korean manufacturers a brief should name?
Samsung Medison and Alpinion for ultrasound, Osstem for dental implants, Vatech for dental imaging, Lunit for AI readout, Seegene for molecular IVD.
Do the Big Five hospitals buy the same way?
No. Asan, Samsung Medical Center, Severance, Seoul National and St. Mary’s run separate committees and vendor codes. A win at one is not a win at five.
What does BioNixus study on Korean device accounts?
MFDS-to-SKU traces, HIRA-code timing interviews, Big Five committee walks, and clinic-chain installed-base counts for Osstem and Vatech.
Is this a Korean market-share ranking?
No. Entries are grouped by role and appear because they recur in BioNixus tertiary and clinic fieldwork; order is not turnover.
Sources
Data sources & methodology
This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in South Korea. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.
Primary register: MFDS — Ministry of Food and Drug Safety, medical device approval and surveillance, consulted 2026-09-05. Company classification (Local / MNC / Regional / distributors & service partners) reflects ownership and role in South Korea, not size.
- MFDS medical-device approval and post-market notices, consulted 2026
- NHIS and HIRA reimbursement-code and claim-review publications
- Samsung Medison, Alpinion, Osstem, Vatech, Lunit and Seegene published company descriptions
- BioNixus Korea Big Five and clinic-chain hospital fieldwork, 2023–2026
BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.
48-hour proposal
Need device-level competitive data in South Korea?
Installed base, procedure volumes, surgeon preference and tender outcomes by hospital — fielded across public and private operators.
Planning research in South Korea?
Primary research, market access & HEOR. Proposals within 48 hours.